ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

ANI Pharma (ANIP) Misses Q2 EPS by 21c, Updates Guidance

August 7, 2018 8:38 AM EDT

ANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $1.13, $0.21 worse than the analyst estimate of $1.34. Revenue for the quarter came in at $47.3 million versus the consensus estimate of $51.42 million.

GUIDANCE:

ANI Pharma sees FY2018 EPS of $4.80-$5.27, versus the consensus... More